Cannabinoid reference entry

CBGA

The A in CBGA changes the chemistry

CBGA is cannabigerolic acid, an acidic phytocannabinoid and a biosynthetic precursor in cannabis chemistry. It is not CBG with a different spelling. The distinction matters because acidic cannabinoids can change during processing and heating. A page that lists CBGA is referring to the acid form measured in that sample, not automatically to its neutral counterpart.

Plant and analytical studies track change over time

A 2024 plant-chemistry study compared glandular contents with air-dried Cannabis sativa inflorescence and found different proportions of CBGA and other acidic cannabinoids. A separate chromatography study measured CBGA decarboxylation and found different behaviour from THCA in the tested analytical system. Those results describe sampled material and controlled laboratory conditions. They do not measure a patient response.

The mouse seizure results went in different directions

An animal investigation used both an Scn1a epilepsy model and electroshock seizure tests. CBGA reduced seizure responses in some tests but increased spontaneous seizure frequency in the Scn1a model. That divergence is a useful warning about turning one preclinical result into a simple treatment story. It is mouse evidence, not a human epilepsy trial.

What a CBGA entry can and cannot identify

CBGA and CBG should remain separate entries on a laboratory report. The result needs its method, batch and processing context attached. The cited evidence contains no controlled human trial of isolated CBGA for a patient outcome. It therefore cannot establish a predictable conversion to CBG, an epilepsy treatment effect or an individual response. Compare it with the CBG reference when both names appear in the same record.

Related conditions

Sources

For broader terminology, browse the UK Medical Cannabis Glossary.

Read next

Other cannabinoid entries